• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » FDA sued for job history of advisory committee members

FDA sued for job history of advisory committee members

May 2, 2016
CenterWatch Staff

Public Citizen has filed a Freedom of Information Act (FOIA) lawsuit against the FDA, asking the agency to post unredacted copies of the curricula vitae (CV) of advisory committee members on its website.

The FDA has approximately 50 advisory committees composed of outside experts who advise the agency on issues such as whether the FDA should approve new medical products or change a product’s labeling. The FDA frequently follows the recommendations of advisory committees. Despite the fact that CVs are created for the specific purpose of being shared, the FDA redacts information from most of the advisory committee members’ CVs posted on its website.

The FDA blacks out information in the CVs about the dates of degrees conferred, the names of professional colleagues and mentors, the amounts of grants received from private companies, and the names of presentations and unpublished articles. Redactions of such information deny the public access to information that may bear on the qualifications, backgrounds and potential biases of advisory committee members, Public Citizen maintains.

Dr. Michael Carome, an advisory committee member and director of Public Citizen’s Health Research Group, told the FDA when he provided his CV that the CV could be made public without any redactions. Yet when the FDA posted it online, the agency redacted it anyway.

“The agency redacted my military awards and service and the amount of one National Kidney Foundation grant long since closed out,” said Carome. “The notion that releasing this information would be an invasion of privacy or that it was confidential would be hard to understand anyway—but after I specifically had stated that the CV could be posted in full, it is ridiculous.”

Believing the redactions to be unjustified, Public Citizen filed suit to obtain unredacted copies of the CVs posted on the FDA’s website. Public Citizen also seeks an order requiring the FDA to post unredacted copies of the CVs on its website going forward, because FOIA requires agencies to post frequently requested records online and the FDA’s website concedes that advisory committee members’ CVs are frequently requested.

The FDA claims that these redactions protect confidential and private information, but CVs are compiled by individuals specifically for the purpose of touting their backgrounds and accomplishments. Each person chooses what information to include and how to state it on her own CV.

“Confidential information does not appear on documents crafted for the express purpose of sharing with other people,” said Rachel Clattenburg, the lead Public Citizen attorney on the case. “The redactions are unjustified and show that the FDA has wasted considerable time going through CVs to black out information. We worry that the FDA’s treatment of advisory committee member CVs is an indication that the agency favors secrecy over disclosure.”

Upcoming Events

  • 26Jan

    Reducing Complexity in Starting Clinical Trials – More Patients, Faster Startup

  • 27Jan

    Medical Device Clinical Trials in China: Latest Regulatory Developments

  • 11Feb

    Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • TechInnovation-360x240.png

    Pace of Technology Innovation in Trials Could Slow After Pandemic Eases

  • AskTheExperts-360x240.png

    Ask the Experts: Certifying and Maintaining Copies of Original Source Documents

  • Resources-360x240.png

    Trial Complexity, Endpoints Continue to Increase, Stretching Site Resources

  • FocusinRed-360x240.png

    Return to Focus on Risk Management Postpandemic Could Prove Challenging to Sites

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing